Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development. - Wikidata - awgldk - TriplyDB

Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development.

Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development.

http://www.wikidata.org/entity/Q35056015

about

Characterization of a UBC13 kinase in Plasmodium falciparum Structure-based design of novel small-molecule inhibitors of Plasmodium falciparum.Proteases in malaria parasites - a phylogenomic perspective.Mefloquine exposure induces cell cycle delay and reveals stage-specific expression of the pfmdr1 gene.Antimalarial drug discovery: targeting protein kinases.Novel antimalarial drug targets: hope for new antimalarial drugs.In silico three-dimensional pharmacophores for aiding the discovery of the Pfmrk (Plasmodium cyclin-dependent protein kinases) specific inhibitors for the therapeutic treatment of malaria.High-throughput screening with the Eimeria tenella CDC2-related kinase2/cyclin complex EtCRK2/EtCYC3a.In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.

P2860

Q27976461-73975F32-67BE-4290-94E9-18EA97018E91 Q33567066-CED16D40-8340-4A53-9D22-919C5BF11B1B Q35228790-25019F1D-7E71-4164-ACEE-273115B6D5C1 Q36558336-E88C27D0-84C1-4A68-BA62-E36EDE962771 Q36734919-3D909847-38A8-484C-8935-0FCF78D9DA5B Q37960187-C3B61D23-C183-4F46-8A41-E1E320F81963 Q38088782-6C2E346A-17DE-4B88-8587-50F6868510CB Q42112474-5A73538A-E4EA-41DE-B5DF-2511C758A0F3 Q45154541-6C975307-0DC1-4E87-8262-C15FE2355513

P2860

Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development.

http://www.wikidata.org/entity/Q35056015

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Cyclin-dependent protein kinas ...... antimalarial drug development.

@ast

Cyclin-dependent protein kinas ...... antimalarial drug development.

@en

type

label

Cyclin-dependent protein kinas ...... antimalarial drug development.

@ast

Cyclin-dependent protein kinas ...... antimalarial drug development.

@en

prefLabel

Cyclin-dependent protein kinas ...... antimalarial drug development.

@ast

Cyclin-dependent protein kinas ...... antimalarial drug development.

@en

P1433

Q35056015-3C8B2202-54A9-4598-986B-3C940677D842

P1476

Q35056015-AC0CFD7B-C553-4A15-BE17-50D1B445B58E

P2093

Q35056015-1A9048C8-36A5-4C1D-8E02-1248B322B821

Q35056015-BD516983-1681-4E6E-8D9B-FB45FEB11272

P2860

Q35056015-023F530C-AD01-4136-A40D-EA6B4B13E02A

Q35056015-0337D166-A103-482F-B6C9-D2DB8D60BAE8

Q35056015-07C21119-6D3B-4A18-ACF6-D6951E3AC1BA

Q35056015-093EBFAD-4F06-4324-B268-6CF5DA8A2BDC

Q35056015-1EC49EEC-55D1-4DE4-AD2A-14D1E7FAD890

Q35056015-2E7378E0-F9C7-4294-A856-84EC83CAD491

Q35056015-30B7DAEE-A30F-494E-BCC1-BCCF3C846541

Q35056015-39F29841-FA01-4D87-ACBD-FD1FF2FF4F8E

Q35056015-48C957AF-DDE4-4289-89B0-8EC6D11C436A

Q35056015-4CA8F3C4-8A24-4FC4-A486-1B34486C5CA0

P304

Q35056015-383E57CB-80A9-475E-B70D-20392ACAAB67

P31

Q35056015-C65676D1-98B0-43B9-BE74-DDFFC64E34DB

P356

Q35056015-F3E136D7-55E1-41E9-AFC9-769CD824A1A6

P407

Q35056015-8C746676-E64B-497E-99A3-4A8F7B50AAEB

P433

Q35056015-A3977358-D2C9-45ED-998D-A5C27B6AF700

P478

Q35056015-BBF18E83-6DB9-430A-A38C-E89E95A5626F

P577

Q35056015-30FED86E-71A4-40A2-BAF1-93FB45207425

P698

Q35056015-F81FBB83-1943-4097-BDA0-1EF513C83EB6

P921

Q35056015-099F4598-4038-4486-8F22-33DF43AFBED3

P356

P1433

Expert Opinion on Therapeutic Targets

P1476

Cyclin-dependent protein kinas ...... antimalarial drug development.

@en

P2093

Jeanne A Geyer

http://www.w3.org/2001/XMLSchema#string

Norman C Waters

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis of cyclin-dependent kinase activation by phosphorylation

Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity

Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors

Crystallographic approach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein

Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis

Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex

The Cdk-activating kinase (CAK) from budding yeast.

KIN28 encodes a C-terminal domain kinase that controls mRNA transcription in Saccharomyces cerevisiae but lacks cyclin-dependent kinase-activating kinase (CAK) activity.

Cyclin H activation and drug susceptibility of the Pfmrk cyclin dependent protein kinase from Plasmodium falciparum

Plasmodium falciparum protein kinase 5 and the malarial nuclear division cycles

P304

7-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.7.1.7

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12556199

http://www.w3.org/2001/XMLSchema#string

P921